These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21398519)

  • 1. Difference in stability of the N-domain underlies distinct intracellular properties of the E1064A and H1069Q mutants of copper-transporting ATPase ATP7B.
    Dmitriev OY; Bhattacharjee A; Nokhrin S; Uhlemann EM; Lutsenko S
    J Biol Chem; 2011 May; 286(18):16355-62. PubMed ID: 21398519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distinct functional properties of the nucleotide-binding domain of ATP7B, the human copper-transporting ATPase: analysis of the Wilson disease mutations E1064A, H1069Q, R1151H, and C1104F.
    Morgan CT; Tsivkovskii R; Kosinsky YA; Efremov RG; Lutsenko S
    J Biol Chem; 2004 Aug; 279(35):36363-71. PubMed ID: 15205462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the invariant His-1069 in folding and function of the Wilson's disease protein, the human copper-transporting ATPase ATP7B.
    Tsivkovskii R; Efremov RG; Lutsenko S
    J Biol Chem; 2003 Apr; 278(15):13302-8. PubMed ID: 12551905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence variation in the ATP-binding domain of the Wilson disease transporter, ATP7B, affects copper transport in a yeast model system.
    Hsi G; Cullen LM; Macintyre G; Chen MM; Glerum DM; Cox DW
    Hum Mutat; 2008 Apr; 29(4):491-501. PubMed ID: 18203200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular events initiating exit of a copper-transporting ATPase ATP7B from the trans-Golgi network.
    Hasan NM; Gupta A; Polishchuk E; Yu CH; Polishchuk R; Dmitriev OY; Lutsenko S
    J Biol Chem; 2012 Oct; 287(43):36041-50. PubMed ID: 22898812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability and ATP binding of the nucleotide-binding domain of the Wilson disease protein: effect of the common H1069Q mutation.
    Rodriguez-Granillo A; Sedlak E; Wittung-Stafshede P
    J Mol Biol; 2008 Nov; 383(5):1097-111. PubMed ID: 18692069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure of the N-domain of Wilson disease protein: distinct nucleotide-binding environment and effects of disease mutations.
    Dmitriev O; Tsivkovskii R; Abildgaard F; Morgan CT; Markley JL; Lutsenko S
    Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5302-7. PubMed ID: 16567646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Wilson disease mutations revealed that interactions between different ATP7B mutants modify their properties.
    Roy S; McCann CJ; Ralle M; Ray K; Ray J; Lutsenko S; Jayakanthan S
    Sci Rep; 2020 Aug; 10(1):13487. PubMed ID: 32778786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse functional properties of Wilson disease ATP7B variants.
    Huster D; Kühne A; Bhattacharjee A; Raines L; Jantsch V; Noe J; Schirrmeister W; Sommerer I; Sabri O; Berr F; Mössner J; Stieger B; Caca K; Lutsenko S
    Gastroenterology; 2012 Apr; 142(4):947-956.e5. PubMed ID: 22240481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of p38 MAPK and JNK as new targets for correction of Wilson disease-causing ATP7B mutants.
    Chesi G; Hegde RN; Iacobacci S; Concilli M; Parashuraman S; Festa BP; Polishchuk EV; Di Tullio G; Carissimo A; Montefusco S; Canetti D; Monti M; Amoresano A; Pucci P; van de Sluis B; Lutsenko S; Luini A; Polishchuk RS
    Hepatology; 2016 Jun; 63(6):1842-59. PubMed ID: 26660341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B.
    Braiterman LT; Murthy A; Jayakanthan S; Nyasae L; Tzeng E; Gromadzka G; Woolf TB; Lutsenko S; Hubbard AL
    Proc Natl Acad Sci U S A; 2014 Apr; 111(14):E1364-73. PubMed ID: 24706876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin.
    van den Berghe PV; Stapelbroek JM; Krieger E; de Bie P; van de Graaf SF; de Groot RE; van Beurden E; Spijker E; Houwen RH; Berger R; Klomp LW
    Hepatology; 2009 Dec; 50(6):1783-95. PubMed ID: 19937698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical roles for the COOH terminus of the Cu-ATPase ATP7B in protein stability, trans-Golgi network retention, copper sensing, and retrograde trafficking.
    Braiterman L; Nyasae L; Leves F; Hubbard AL
    Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G69-81. PubMed ID: 21454443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B.
    de Bie P; van de Sluis B; Burstein E; van de Berghe PV; Muller P; Berger R; Gitlin JD; Wijmenga C; Klomp LW
    Gastroenterology; 2007 Oct; 133(4):1316-26. PubMed ID: 17919502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p.H1069Q mutation in ATP7B and biochemical parameters of copper metabolism and clinical manifestation of Wilson's disease.
    Gromadzka G; Schmidt HH; Genschel J; Bochow B; Rodo M; Tarnacka B; Litwin T; Chabik G; Członkowska A
    Mov Disord; 2006 Feb; 21(2):245-8. PubMed ID: 16211609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A structural model of the copper ATPase ATP7B to facilitate analysis of Wilson disease-causing mutations and studies of the transport mechanism.
    Schushan M; Bhattacharjee A; Ben-Tal N; Lutsenko S
    Metallomics; 2012 Jul; 4(7):669-78. PubMed ID: 22692182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular copper levels determine the phenotype of the Arg875 variant of ATP7B/Wilson disease protein.
    Gupta A; Bhattacharjee A; Dmitriev OY; Nokhrin S; Braiterman L; Hubbard AL; Lutsenko S
    Proc Natl Acad Sci U S A; 2011 Mar; 108(13):5390-5. PubMed ID: 21406592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From clinical and biochemical to molecular genetic diagnosis of Wilson disease in Latvia.
    Krumina A; Keiss J; Sondore V; Chernushenko A; Cernevska G; Zarina A; Micule I; Piekuse L; Kreile M; Lace B; Krumina Z; Rozentale B
    Genetika; 2008 Oct; 44(10):1379-84. PubMed ID: 19062534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of missense mutations in ATP7B: Wilson disease mutation or normal variant?
    Forbes JR; Cox DW
    Am J Hum Genet; 1998 Dec; 63(6):1663-74. PubMed ID: 9837819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apical targeting and Golgi retention signals reside within a 9-amino acid sequence in the copper-ATPase, ATP7B.
    Braiterman L; Nyasae L; Guo Y; Bustos R; Lutsenko S; Hubbard A
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G433-44. PubMed ID: 19033537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.